{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:01:05Z","timestamp":1793138465048,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T00:00:00Z","timestamp":1494892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12020-017-1313-6","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T22:38:36Z","timestamp":1494887916000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-4445","authenticated-orcid":false,"given":"Yoshitaka","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-0550","authenticated-orcid":false,"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohbora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","volume":"143","author":"M Hamaguchi","year":"2005","unstructured":"M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, K. Fujii, T. Omatsu, T. Nakajima, H. Sarui, M. Shimazaki, T. Kato, J. Okuda, K. Ida, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 143, 722\u2013728 (2005)","journal-title":"Ann. Intern. Med."},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1530\/EJE-14-0540","volume":"171,","author":"M Bl\u00fcher","year":"2014","unstructured":"M. Bl\u00fcher, Are metabolically healthy obese individuals really healthy? Eur. J. Endocrinol. 171,, R209\u2013R219 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2215\/CJN.08980914","volume":"10","author":"Y Hashimoto","year":"2015","unstructured":"Y. Hashimoto, M. Tanaka, H. Okada, T. Senmaru, M. Hamaguchi, M. Asano, M. Yamazaki, Y. Oda, G. Hasegawa, H. Toda, N. Nakamura, M. Fukui, Metabolically healthy obesity and risk of incident CKD. Clin. J. Am. Soc. Nephrol. 10, 578\u2013583 (2015)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.metabol.2015.03.009","volume":"64","author":"N Eckel","year":"2015","unstructured":"N. Eckel, K. M\u00fchlenbruch, K. Meidtner, H. Boeing, N. Stefan, M.B. Schulze, Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metabolism 64, 862\u2013871 (2015)","journal-title":"Metabolism"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1210\/jc.2013-4427","volume":"99","author":"Y Heianza","year":"2014","unstructured":"Y. Heianza, Y. Arase, H. Tsuji, K. Fujihara, K. Saito, S.D. Hsieh, S. Tanaka, S. Kodama, S. Hara, H. Sone, Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J. Clin. Endocrinol. Metab. 99, 2952\u20132960 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1313_CR6","doi-asserted-by":"publisher","unstructured":"J. Zhang, H. Jiang, J. Chen, Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis. Oncotarget. in press. (2016). doi:\n                    10.18632\/oncotarget.10915","DOI":"10.18632\/oncotarget.10915"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"CK Kramer","year":"2013","unstructured":"C.K. Kramer, B. Zinman, R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann. Intern. Med. 159, 758\u2013769 (2013)","journal-title":"Ann. Intern. Med."},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ijo.2015.151","volume":"40","author":"R Dobson","year":"2016","unstructured":"R. Dobson, M.I. Burgess, V.S. Sprung, A. Irwin, M. Hamer, J. Jones, C. Daousi, V. Adams, G.J. Kemp, F. Shojaee-Moradie, M. Umpleby, D.J. Cuthbertson, Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int. J. Obes. 40, 153\u2013161 (2016)","journal-title":"Int. J. Obes."},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jdiacomp.2013.11.010","volume":"28","author":"NJ Coleman","year":"2014","unstructured":"N.J. Coleman, J. Miernik, L. Philipson, L. Fogelfeld, Lean versus obese diabetes mellitus patients in the United States minority population. J. Diabetes Complicat 28, 500\u2013505 (2014)","journal-title":"J. Diabetes Complicat"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40519-015-0215-y","volume":"21","author":"L Renzo Di","year":"2016","unstructured":"L. Di Renzo, E. Tyndall, P. Gualtieri, C. Carboni, R. Valente, A.S. Ciani, M.G. Tonini, A. De Lorenzo, Association of body composition and eating behavior in the normal weight obese syndrome. Eat. Weight. Disord. 21, 99\u2013106 (2016)","journal-title":"Eat. Weight. Disord."},{"key":"1313_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ajcn\/85.1.40","volume":"85","author":"A Lorenzo De","year":"2007","unstructured":"A. De Lorenzo, V. Del Gobbo, M.G. Premrov, M. Bigioni, F. Galvano, L. Di Renzo, Normal-weight obese syndrome: early inflammation? Am. J. Clin. Nutr. 85, 40\u201345 (2007)","journal-title":"Am. J. Clin. Nutr."},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2174\/1574887109666141216111143","volume":"9","author":"M Masarone","year":"2014","unstructured":"M. Masarone, A. Federico, L. Abenavoli, C. Loguercio, M. Persico, Non alcoholic fatty liver: epidemiology and natural history. Rev. Recent Clin. Trials 9, 126\u2013133 (2014)","journal-title":"Rev. Recent Clin. Trials"},{"key":"1313_CR13","first-page":"1388","volume":"64","author":"European Association for the Study of the Liver (EASL).; European Association for the Study of Diabetes (EASD).; European Association for the Study of Obesity (EASO).","year":"2016","unstructured":"European Association for the Study of the Liver (EASL).; European Association for the Study of Diabetes (EASD).; European Association for the Study of Obesity (EASO)., EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388\u20131402 (2016)","journal-title":"J. Hepatol."},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/liv.12912","volume":"36","author":"T Fukuda","year":"2016","unstructured":"T. Fukuda, M. Hamaguchi, T. Kojima, Y. Hashimoto, A. Ohbora, T. Kato, N. Nakamura, M. Fukui, The impact of nonalcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. Liver Int. 36, 275\u2013283 (2016)","journal-title":"Liver Int."},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","volume":"65","author":"JM Hazlehurst","year":"2016","unstructured":"J.M. Hazlehurst, C. Woods, T. Marjot, J.F. Cobbold, J.W. Tomlinson, Non-alcoholic fatty liver disease and diabetes. Metabolism 65, 1096\u20131108 (2016)","journal-title":"Metabolism"},{"key":"1313_CR16","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"G. Musso, R. Gambino, J.H. Tabibian, M. Ekstedt, S. Kechagias, M. Hamaguchi, R. Hultcrantz, H. Hagstr\u00f6m, S.K. Yoon, P. Charatcharoenwitthaya, J. George, F. Barrera, S. Hafli\u00f0ad\u00f3ttir, E.S. Bj\u00f6rnsson, M.J. Armstrong, L.J. Hopkins, X. Gao, S. Francque, A. Verrijken, Y. Yilmaz, K.D. Lindor, M. Charlton, R. Haring, M.M. Lerch, R. Rettig, H. V\u00f6lzke, S. Ryu, G. Li, L.L. Wong, M. Machado, H. Cortez-Pinto, K. Yasui, M. Cassader, Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 11, e1001680 (2014)","journal-title":"PLoS Med."},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2337\/dc15-1182","volume":"39","author":"G Musso","year":"2016","unstructured":"G. Musso, M. Cassader, S. Cohney, F. De Michieli, S. Pinach, F. Saba, R. Gambino, Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities. Diabetes Care 39, 1830\u20131845 (2016)","journal-title":"Diabetes Care"},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","volume":"13","author":"M Hamaguchi","year":"2007","unstructured":"M. Hamaguchi, T. Kojima, N. Takeda, C. Nagata, J. Takeda, H. Sarui, Y. Kawahito, N. Yoshida, A. Suetsugu, T. Kato, J. Okuda, K. Ida, T. Yoshikawa, Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J. Gastroenterol. 13, 1579\u20131584 (2007)","journal-title":"World J. Gastroenterol."},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","volume":"65","author":"A Lonardo","year":"2016","unstructured":"A. Lonardo, S. Sookoian, C.J. Pirola, G. Targher, Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65, 1136\u20131150 (2016)","journal-title":"Metabolism"},{"key":"1313_CR20","first-page":"4731","volume":"20","author":"A Federico","year":"2016","unstructured":"A. Federico, M. Dallio, M. Masarone, M. Persico, C. Loguercio, The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Eur. Rev. Med. Pharmacol. Sci. 20, 4731\u20134741 (2016)","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3748\/wjg.v22.i31.7006","volume":"22","author":"L Abenavoli","year":"2016","unstructured":"L. Abenavoli, N. Milic, L. Di Renzo, T. Preveden, M. Medi\u0107-Stojanoska, A. De Lorenzo, Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J. Gastroenterol. 22, 7006\u20137016 (2016)","journal-title":"World J. Gastroenterol."},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"16831","DOI":"10.3748\/wjg.v20.i45.16831","volume":"20","author":"L Abenavoli","year":"2014","unstructured":"L. Abenavoli, N. Milic, V. Peta, F. Alfieri, A. De Lorenzo, S. Bellentani, Alimentary regimen in non-alcoholic fatty liver disease: mediterranean diet. World J. Gastroenterol. 20, 16831\u201316840 (2014)","journal-title":"World J. Gastroenterol."},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","volume":"18","author":"M Hamaguchi","year":"2012","unstructured":"M. Hamaguchi, N. Takeda, T. Kojima, A. Ohbora, T. Kato, H. Sarui, M. Fukui, C. Nagata, J. Takeda, Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J. Gastroenterol. 18, 1508\u20131516 (2012)","journal-title":"World J. Gastroenterol."},{"key":"1313_CR24","first-page":"489","volume":"88","author":"L Abenavoli","year":"2015","unstructured":"L. Abenavoli, L. DI Renzo, P.H. Guzzi, R. Pellicano, N. Milic, A. De Lorenzo, Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship. Clujul Med. 88, 489\u2013493 (2015)","journal-title":"Clujul Med."},{"key":"1313_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","volume":"8","author":"AJ McCullough","year":"2004","unstructured":"A.J. McCullough, The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 8, 521\u2013533 (2004)","journal-title":"Clin. Liver Dis."},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1111\/j.1572-0241.2007.01274.x","volume":"102","author":"A Suzuki","year":"2007","unstructured":"A. Suzuki, P. Angulo, J. St Sauver, A. Muto, T. Okada, K. Lindor, Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am. J. Gastroenterol. 102, 1912\u20131919 (2007)","journal-title":"Am. J. Gastroenterol."},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/jgh.12786","volume":"30","author":"Y Hashimoto","year":"2015","unstructured":"Y. Hashimoto, M. Hamaguchi, T. Kojima, Y. Ohshima, A. Ohbora, T. Kato, N. Nakamura, M. Fukui, The modest alcohol consumption reduces the incidence of fatty liver in men; a population based large scale cohort study. J. Gastroenterol. Hepatol. 30, 546\u2013552 (2015)","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Y. Fukuda, Y. Hashimoto, M. Hamaguchi, T. Fukuda, N. Nakamura, A. Ohbora, T. Kato, T. Kojima, M. Fukui, Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 36, 713\u2013720 (2016)","journal-title":"Liver Int."},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/oxfordjournals.aje.a117618","volume":"142","author":"DJ Aaron","year":"1995","unstructured":"D.J. Aaron, A.M. Kriska, S.R. Dearwater, J.A. Cauley, K.F. Metz, R.E. LaPorte, Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am. J. Epidemiol 142, 191\u2013201 (1995)","journal-title":"Am. J. Epidemiol"},{"key":"1313_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1373\/clinchem.2006.078980","volume":"53","author":"S Ryu","year":"2007","unstructured":"S. Ryu, Y. Chang, D.I. Kim, W.S. Kim, B.S. Suh, gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin. Chem. 53, 71\u201377 (2007)","journal-title":"Clin. Chem."},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"K.G. Alberti, P. Zimmet, J. Shaw, Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Med. 23, 469\u2013480 (2006)","journal-title":"Diabet. Med."},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/bmj.312.7027.377","volume":"312","author":"M Ashwell","year":"1996","unstructured":"M. Ashwell, S. Lejeune, K. McPherson, Ratio of waist circumference to height may be better indicator of need for weight management. BMJ 312, 377 (1996)","journal-title":"BMJ"},{"key":"1313_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/oby.2004.48","volume":"12","author":"D Gallagher","year":"2004","unstructured":"D. Gallagher, Overweight and obesity BMI cut-offs and their relation to metabolic disorders in Koreans\/Asians. Obes. Res. 12, 440\u2013441 (2004)","journal-title":"Obes. Res."},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12020-015-0587-9","volume":"50","author":"Y Hashimoto","year":"2015","unstructured":"Y. Hashimoto, M. Tanaka, T. Kimura, N. Kitagawa, M. Hamaguchi, M. Asano, M. Yamazaki, Y. Oda, H. Toda, N. Nakamura, M. Fukui, Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study. Endocrine 50, 390\u2013396 (2015)","journal-title":"Endocrine"},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.2169\/internalmedicine.55.7000","volume":"55","author":"T Kimura","year":"2016","unstructured":"T. Kimura, Y. Hashimoto, M. Tanaka, M. Asano, M. Yamazaki, Y. Oda, H. Toda, Y. Marunaka, N. Nakamura, M. Fukui, Sodium-chloride difference and metabolic syndrome: a population-based large-scale cohort study. Intern. Med. 55, 3085\u20133090 (2016)","journal-title":"Intern. Med."},{"key":"1313_CR36","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"M. Hamaguchi, T. Kojima, Y. Itoh, Y. Harano, K. Fujii, T. Nakajima, T. Kato, N. Takeda, J. Okuda, K. Ida, Y. Kawahito, T. Yoshikawa, T. Okanoue, The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 102, 2708\u20132715 (2007)","journal-title":"Am. J. Gastroenterol."},{"key":"1313_CR37","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","volume":"34","author":"CD Byrne","year":"2014","unstructured":"C.D. Byrne, G. Targher, Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 34, 1155\u20131161 (2014)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/er.2008-0009","volume":"29","author":"N Stefan","year":"2008","unstructured":"N. Stefan, K. Kantartzis, H.U. H\u00e4ring, Causes and metabolic consequences of Fatty liver. Endocr. Rev. 29, 939\u2013960 (2008)","journal-title":"Endocr. Rev."},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1097\/MEG.0000000000000682","volume":"28","author":"Y Hashimoto","year":"2016","unstructured":"Y. Hashimoto, M. Hamaguchi, T. Fukuda, N. Nakamura, A. Ohbora, T. Kojima, M. Fukui, BMI history and risk of incident fatty liver: a population-based large-scale cohort study. Eur. J. Gastroenterol. Hepatol. 28, 1188\u20131193 (2016)","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/CS20140553","volume":"128","author":"R Taylor","year":"2015","unstructured":"R. Taylor, R.R. Holman, Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin. Sci. 128, 405\u2013410 (2015)","journal-title":"Clin. Sci."},{"key":"1313_CR41","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"J.P. Despr\u00e9s, Body fat distribution and risk of cardiovascular disease: an update. Circulation 126, 1301\u20131313 (2012)","journal-title":"Circulation"},{"key":"1313_CR42","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/ijo.2015.75","volume":"39","author":"YC Hwang","year":"2015","unstructured":"Y.C. Hwang, T. Hayashi, W.Y. Fujimoto, S.E. Kahn, D.L. Leonetti, M.J. McNeely, E.J. Boyko, Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int. J. Obes. 39, 1365\u20131370 (2015)","journal-title":"Int. J. Obes.."},{"key":"1313_CR43","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/oby.21087","volume":"23","author":"MD Fung","year":"2015","unstructured":"M.D. Fung, K.L. Canning, P. Mirdamadi, C.I. Ardern, J.L. Kuk, Lifestyle and weight predictors of a healthy overweight profile over a 20-year follow-up. Obesity 23, 1320\u20131325 (2015)","journal-title":"Obesity"},{"key":"1313_CR44","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/ijo.2015.56","volume":"39","author":"Z Cui","year":"2015","unstructured":"Z. Cui, K.P. Truesdale, P.T. Bradshaw, J. Cai, J. Stevens, Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: the atherosclerosis risk in communities study. Int. J. Obes. 39, 1203\u20131208 (2015)","journal-title":"Int. J. Obes."},{"key":"1313_CR45","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1007\/s00125-014-3380-z","volume":"57","author":"YC Klimentidis","year":"2014","unstructured":"Y.C. Klimentidis, Z. Chen, A. Arora, C.H. Hsu, Association of physical activity with lower type 2 diabetes incidence is weaker among individuals at high genetic risk. Diabetologia 57, 2530\u20132534 (2014)","journal-title":"Diabetologia"},{"key":"1313_CR46","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/MEG.0000000000000736","volume":"28","author":"T Fukuda","year":"2016","unstructured":"T. Fukuda, M. Hamaguchi, T. Kojima, K. Mitsuhashi, Y. Hashimoto, A. Ohbora, T. Kato, N. Nakamura, M. Fukui, Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. Eur. J. Gastroenterol. Hepatol. 28, 1443\u20131449 (2016)","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"1313_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/obr.12405","volume":"17","author":"Y Hashimoto","year":"2016","unstructured":"Y. Hashimoto, T. Fukuda, C. Oyabu, M. Tanaka, M. Asano, M. Yamazaki, M. Fukui, Impact of low-carbohydrate diet on body composition: meta-analysis of randomized controlled studies. Obes. Rev. 17, 499\u2013509 (2016)","journal-title":"Obes. Rev."},{"key":"1313_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00592-012-0445-7","volume":"50","author":"N Daniele Di","year":"2013","unstructured":"N. Di Daniele, L. Petramala, L. Di Renzo, F. Sarlo, D.G. Della Rocca, M. Rizzo, V. Fondacaro, L. Iacopino, C.J. Pepine, A. De Lorenzo, Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean diet in obese patients with metabolic syndrome. Acta Diabetol. 50, 409\u2013416 (2013)","journal-title":"Acta Diabetol."},{"key":"1313_CR49","first-page":"329","volume":"21","author":"G Merra","year":"2017","unstructured":"G. Merra, S. Gratteri, A. De Lorenzo, S. Barrucco, M.A. Perrone, E. Avolio, S. Bernardini, M. Marchetti, L. Di Renzo, Effects of very-low-calorie diet on body composition, metabolic state, and genes expression: a randomized double-blind placebo-controlled trial. Eur. Rev. Med. Pharmacol. Sci. 21, 329\u2013345 (2017)","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"R. Hernaez, M. Lazo, S. Bonekamp, I. Kamel, F.L. Brancati, E. Guallar, J.M. Clark, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1082\u20131090 (2011)","journal-title":"Hepatology"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1313-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:22:55Z","timestamp":1567768975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1313-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1313-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727619683.793542212","asserted-by":"object"}]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,16]]},"assertion":[{"value":"2 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M. Fukui has received grant and research support from AstraZeneca plc, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., Kyowa Hakko Kirin Company Ltd., Kowa Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Nippon Chemiphar Company Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Sanofi K.K., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Terumo Co. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. M. Fukui, his immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. M. Fukui received no current funding for this study and this does not alter their adherence to all of the journal policies on sharing data and materials. The remaining authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and an independent ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}